Calcipotriol plus Betamethasone Dipropionate Gel Compared to DAIVONEX/DOVONEX Scalp Solution in Patients with Scalp Psoriasis. A phase III study comparing a gel containing calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate) used once daily with calcipotriol 50 mcg/ml in scalp solution used twice daily, in the treatment of scalp psoriasis.

Trial Profile

Calcipotriol plus Betamethasone Dipropionate Gel Compared to DAIVONEX/DOVONEX Scalp Solution in Patients with Scalp Psoriasis. A phase III study comparing a gel containing calcipotriol 50 mcg/g plus betamethasone 0.5 mg/g (as dipropionate) used once daily with calcipotriol 50 mcg/ml in scalp solution used twice daily, in the treatment of scalp psoriasis.

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Jun 2013

At a glance

  • Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Calcipotriol
  • Indications Plaque psoriasis
  • Focus Registrational; Therapeutic Use
  • Sponsors LEO Pharma
  • Most Recent Events

    • 12 Jun 2013 New source identified and integrated (ClinicalTrials.gov: US National Institutes of Health, NCT00243464).
    • 05 Nov 2010 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top